Breaking News on Pharmaceutical Technology

Headlines > Processing & QC

Product News in Brief

10-Apr-2007 - A round up of recent product releases from across the industry, including new offerings from ABI, Affymetrix, Agilent, Aspectrics, Bio-Rad, Millipore and Waters.

Jasco takes chromatography supercritical

10-Apr-2007 - A new range of preparative scale supercritical fluid chromatography (SFC) and extraction (SFE) products promises cheaper and faster separations and extractions.

Mar Cor buys dialysis water business from GE

10-Apr-2007 - Mar Cor Purification has bought GE Water and Process Technologies' dialysis water business for $30.6m (€22.8m) to become the largest provider of dialysis water in the US, and plans to expand their presence in industrial life science markets.

US stem cell patents 'invalid'

10-Apr-2007 - An initial ruling on the validity of three key US stem cell patents could lead to human embryonic stem cells becoming cheaper and more accessible in the US.

Leveraging the detection of proteins to new limits

10-Apr-2007 - A new millimetre-sized cantilever biosensor has been developed that can detect cells and proteins at lower levels than ever before even under flow conditions, opening the way for new biomarker applications.

New software to aid FDA compliance

05-Apr-2007 - US firm Fullscope has announced the availability of a new software and services package to help pharmaceutical and life science companies achieve and maintain US Food and Drug Administration (FDA) validation.

Akorn warned over GMP failings at Decatur plant

05-Apr-2007 - Akorn, a US pharmaceutical company that develops, manufactures and markets branded and generic diagnostics and therapeutics for niche segments such as ophthalmology, rheumatology and anaesthesia, has received a warning letter from the Food and Drug Administration about significant deviations from current Good Manufacturing Practice (cGMP) regulations at its Decatur, Illinois facility.

Industry News in Brief

05-Apr-2007 - A round up of recent industry news from Abbott Laboratories, Bio-Rad, Horiba, MDS Nordion, Nimblegen, Roche Diagnostics and Thermo Fisher Scientific.

On-line glucose measuring with Finesse

05-Apr-2007 - The first step towards true in-line glucose monitoring for cell culture bioprocesses has been made that will allow greater control over the bioprocess manufacturing.

PerkinElmer buys imaging software specialist

05-Apr-2007 - PerkinElmer have continued to expand their cellular imaging portfolio with the acquisition of software company Improvision.

Vetter wins award for best facility processes

04-Apr-2007 - German contract manufacturer Vetter Pharma-Fertigung has been bestowed with a "facility of the year award" for the processes employed at its new injectables plant.

GE and BAC extend purification pact

02-Apr-2007 - GE Healthcare and the Bio Affinity Company (BAC) have extended their biopharmaceutical partnership to develop purification media for Factor VIII (FVIII) for the treatment of haemophilia A.

Russian laboratory equipment market

30-Mar-2007 - The expansion of a Russian laboratory exhibition highlights the growth in the Russian analytical and laboratory equipment market.

Industry News in Brief

30-Mar-2007 - It's been a busy week for acquisitions in the sector, with Beckmann Coulter purchasing Biosite, Roche acquiring 454, and Shimadzu agreeing to buy the assets of Evolved Digital Systems.

Horiba Jobin Yvon's Activa-M excites for bronze

30-Mar-2007 - A new inductively coupled plasma (ICP) optical emission spectrometer (OES) brings the technique into the hands of the non-expert for the first time.

Extreme pipetting

30-Mar-2007 - Artel is sending three of their employees to the most extreme environments in the US to demonstrate the impact of environmental conditions on pipetted volumes.

Cobra: 'process development is the key'

29-Mar-2007 - Process development is the key when outsourcing clinical supply biomanufacturing to a contractor, according to an industry player.

Chromos expects more cell engineering contracts as finances stabilise

26-Mar-2007 - Canada's Chromos Molecular Systems plans to step up the human resources behind its cell-line engineering business in anticipation of securing further clients within the next few months for its ACE (artificial chromosome expression) System.

Brazil to benefit from $19m biopharma deal

26-Mar-2007 - A Brazilian firm has signed a licensing deal to take advantage of a biopharmaceutical manufacturing technology which will allow the company to locally manufacture complex biopharmaceuticals destined for the South American market.

Agilent and ABI look east

23-Mar-2007 - Both Agilent and Applied Biosystems (ABI) have announced new facilities in Asia and are looking to gain from the increasing pharmaceutical industry presence in the region.

MDS to finalise Molecular Devices acquisition

23-Mar-2007 - MDS is nearing completion of its $615m (€461m) acquisition of the bio-analytical instrument maker Molecular Devices.

Technology Sector wins in the UK budget?

23-Mar-2007 - On the face of it, the UK's 2007 budget looks good for the technology sector with increased R&D tax relief - but is it all as good as it seems?

AZs new PR&D centre leverages Indian chemistry expertise

22-Mar-2007 - AstraZeneca is leveraging the process chemistry expertise accumulated in India's generics industry and universities by opening a $15m (€11.3m) process research and development (PR&D) laboratory next to its existing research centre for tuberculosis in Bangalore.

'Solid waste' gets a makeover

20-Mar-2007 - The US Environmental Protection Agency (EPA) has proposed loosening requirements regarding certain types of recycling activities involving hazardous solid waste materials produced in chemical and pharmaceutical manufacturing.

Pall protests patent breach

20-Mar-2007 - Pall has filed a patent infringement case in the US, claiming another firm is manufacturing and selling a device that violates patent protection of one of Pall's sterile connector products.

Sign up for your free newsletter

Supplier Webinars